stars 1 stars 2 stars 3

PhoenixBio established its proprietary chimeric mouse model, the PXB-mouse®, with a highly humanized liver through years of research and development. With the addition of fresh, isolated human hepatocytes, PXB-cells®, the applications of our products and study services are as wide-ranging as our clients’ research goals. The PXB-mouse animal background (cDNA-uPA/SCID) makes for a robust, consistent model that maintains up to 95% stable human hepatocyte engraftment. The reconstituted humanized liver features structural and biological characteristics commonly observed in normal human livers. The model has proven to be a world-wide gold standard for Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) research, but usage is expanding in the fields of: . Drug Metabolism and Pharmacokinetics, · Human Specific Hepatotoxicity, · Oligonucleotide and Gene-based Therapeutics, · HBV & HBV/HDV, · NASH/NAFLD, · Other human liver-related research fields. PXB-cells® are approximately 95% pure human hepatocytes freshly isolated from the PXB-mouse®. They feature long-term stability of up to 40 days, and allow for consistent supply from the same donor. One unique feature of PXB-cells® and PXB-mice is the ability to directly compare in vitro and in vitro data from the same human donor. With over 300 scientific publications to its credit, the PXB-mouse is the world’s most widely used chimeric mouse model with a humanized liver. A high replacement index, lifespan of up to 2 years, and no secondary drug to maintain mouse liver injury means that your data can translate better to humans than ever before. Please visit our website at https://www.phoenixbio.com/ to learn more about our model and inquire about our offered products and services.

Website https://www.phoenixbio.com/
Revenue $9.8 million
Employees 24 (10 on RocketReach)
Founded 2002
Address 3-4-1 Kagamiyama, Higashi Hiroshima, Hiroshima 739 0046, JP
Phone +81 82-431-0016
Fax (212) 379-6422
Technologies
Industry Biotechnology Research, Manufacturing General, Manufacturing
Web Rank 3 Million
Keywords フェニックスバイオ, Phoenix Bio, フェニックス バイオ 吉里 勝利, 動物実験 受託, フェニックスB
Competitors Thermo Fisher Scientific, Charles River Laboratories, PerkinElmer, Inc., Syngene International Limited, GenScript, Taconic Biosciences, Synthego Corporation, ATUM, Horizon Discovery, Genomatix AG +39 more (view full list)
SIC SIC Code 283 Companies, SIC Code 28 Companies
NAICS NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies

PhoenixBio Questions

The PhoenixBio annual revenue was $9.8 million in 2026.

Takashi Shimada is the President and CEO of PhoenixBio.

10 people are employed at PhoenixBio.

PhoenixBio is based in Higashi Hiroshima, Hiroshima.

The NAICS codes for PhoenixBio are [32541, 32, 3254, 325].

The SIC codes for PhoenixBio are [283, 28].

Top PhoenixBio Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users